Reallotment of FY 2021 Funds: Puerto Rico, 35520-35521 [2021-14314]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES 35520 Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices (2) develops and applies spatial analytic and small area estimation methods to identify geographic variations in chronic disease conditions and related risk factors for public health programming and decision making; (3) provides public health leadership in the prevention of excessive alcohol use and other chronic disease risk factors through public health surveillance, partnerships, and applied research for translation into public health practice; (4) provides public health leadership for epilepsy and other chronic conditions with significant impact on quality of life through surveillance and epidemiologic research, partnerships, applied research and translation, and development and evaluation of programs and interventions in order to expand the reach of evidence-based programs and practices and improve quality of life; and (5) conducts strategic and innovative scientific research on lupus and other evolving and cross-cutting disease issues including determining the burden, developing pilot programs and assessing effectiveness of public health approaches, and works with national, state and local partners to increase awareness, advance knowledge, and inform public health and health care practice. Healthy Schools Branch (CUCPG) (1) Supports state, local, territorial, and tribal agencies and national nongovernmental organizations to develop, implement, evaluate, and disseminate school policy, systems, and environmental strategies and interventions to improve the health of students and school staff by promoting healthy eating, physical activity, and a tobacco-free lifestyle; (2) supports implementation and evaluation of a coordinated approach to school health and best practices in health education; physical education and other physical activity programs; nutrition services; school health services; school counseling, psychological, and social services; health promotion for staff; family and community involvement; and school health and safety policies and environment; (3) provides leadership and consultation on how schools work and how to foster effective collaboration between the public health and education sectors; (4) documents and strengthens the scientific associations among chronic diseaserelated health risks, school-based health promotion initiatives, and academic achievement; (5) evaluates school-based policy, systems, and environmental changes and interventions to improve health behaviors and reduce chronic disease-related health risks among VerDate Sep<11>2014 17:42 Jul 02, 2021 Jkt 253001 children and adolescents; (6) synthesizes and translates scientific research to develop and disseminate guidance, tools, and resources to help schools prevent chronic disease-related risks among children and adolescents; (7) supports efforts of national, state, and local surveillance systems to monitor chronic disease-related health risk behaviors among youth, along with the policies, programs, and practices schools implement to address those health risk behaviors; (8) strengthens efforts of national, state, and local programs to provide high quality professional development services to support school-based chronic disease prevention policies, programs, and practices; (9) in accomplishing the functions listed above, collaborates with other components of CDC and HHS; the U.S. Department of Education, U.S. Department of Agriculture, and other federal agencies; national professional, voluntary, and philanthropic organizations; international agencies; and other organizations as appropriate; and(10) assists other nations in reducing chronic disease-related health risks among children and adolescents and in implementing and improving school health programs. Population Health Surveillance Branch (CUCPH). (1) Plans and directs all activities related to the Behavioral Risk Factor Surveillance System (BRFSS), the nation’s premier system of health surveys that collect state data about United States residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services; (2) coordinates BRFSS surveillance activities across all states and CDC programs; (3) provides support to build state capacity for BRFSS survey operations, data management, analysis, dissemination, and use of the data by state agencies to set public health priorities and monitor public health programs; (4) develops guidelines and criteria for the enhancement of behavioral risk factor surveys at the state and local levels; (5) delivers timely health data of high validity and reliability to states, CDC scientists, the national public health community, and the general public; (6) supports and enhances analysis and dissemination of information from the BRFSS to promote the broad use and application of BRFSS results and findings by policy and decision makers, public health professionals, and other relevant audiences through communication channels and formats appropriate to these constituencies; (7) plans and coordinates cross cutting research related to survey methodology; PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 (8) provides scientific leadership and guidance to surveillance programs to assure highest scientific quality and professional standards related to BRFSS; (9) provides leadership to CDC, states and other organizations to support effective and flexible population health surveillance, including rapidly emerging public health issues and threats; and (10) provides administrative and management support, as required, for states and territories including oversight of BRFSS and other grants, cooperative agreements, and reimbursable agreements. Retitle HIV Surveillance (CVJCE) to HIV Surveillance Branch. Retitle HIV Prevention Capacity and Development Branch (CVJCH) to HIV Prevention Capacity Development Branch. Dia Taylor, Chief Operating Officer (Acting), Centers for Disease Control and Prevention. [FR Doc. 2021–14341 Filed 7–2–21; 8:45 am] BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Community Living Reallotment of FY 2021 Funds: Puerto Rico Administration on Disabilities (AoD), Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS). ACTION: Notice of reallotment of FY 2021 funds. AGENCY: The Administration on Disabilities (AoD) intends to reallot funds under the authority of the Development Disabilities Assistance and Bill of Rights Act of 2000 which states: ‘‘If the Secretary determines that an amount of an allotment to a State for a period (of a fiscal year or longer) will not be required by the State during the period for the purpose for which the allotment was made, the Secretary may reallot the amount.’’ DATES: Funds will be realloted after August 13, 2021 and before September 30, 2021. FOR FURTHER INFORMATION CONTACT: Allison Cruz, Office of Intellectual and Developmental Disabilities, Administration on Disabilities, Administration for Community Living, 330 C St. SW, Washington, DC 20201. Telephone (202) 795–7408. Email allison.cruz@acl.hhs.gov. Please note the telephone number is not toll free. This document will be made available in alternative formats upon request. SUMMARY: E:\FR\FM\06JYN1.SGM 06JYN1 Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices Written correspondence can be sent to Administration for Community Living, U.S. Department of Health and Human Services, 330 C St. SW, Washington, DC 20201. AoD will be reallotting FY 2021 funds awarded to the State Council on Developmental Disabilities (SCDD) located within the Commonwealth of Puerto Rico. This determination is based on the limited reported expenditures and requests for reimbursement over the last several years from the SCDD in the Commonwealth of Puerto Rico. The Puerto Rico SCDD will have up to $1.8 million rescinded and proportionately redistributed to the remaining SCDDs. SCDDs that receive FY 2021 realloted funds will have through the end of FY 2022 to obligate the funds and until the end of FY 2023 to liquidate the funds. Realloted funds for the SCDDs must be used according to the terms as outlined in the FY 2021 Notice of Award for each program. SUPPLEMENTARY INFORMATION: Jennifer G. Johnson, Deputy Commissioner, Administration on Disabilities. [FR Doc. 2021–14314 Filed 7–2–21; 8:45 am] BILLING CODE 4154–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Integrative Health; Notice of Closed Meeting jbell on DSKJLSW7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; Center of Excellence for Research on Complementary and Integrative Health (P01) (CERCIH). Date: July 30, 2021. Time: 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 17:42 Jul 02, 2021 Jkt 253001 Place: National Center for Complementary and Integrative Democracy, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: Martina Schmidt, Ph.D., Chief Office of Scientific Review, National Center for Complementary & Integrative Health, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, 301–594–3456, schmidma@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: June 29, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–14281 Filed 7–2–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Platelets and Red Blood Cells. Date: July 14, 2021. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD 20892, 301–408– 9497, zouai@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member conflict: Topics in Adult Psychopathology. Date: July 30, 2021. Time: 1:00 p.m. to 6:00 p.m. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 35521 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Alyssa Todaro Brooks, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 1000F, Bethesda, MD 20892, (301) 827–9299, brooksaly@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 29, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–14279 Filed 7–2–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Complementary & Integrative Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; Exploratory Clinical Trials of Mind and Body Interventions (MB). Date: July 29, 2021. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Complementary and Integrative, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting). Contact Person: SUSHMITA Purkayastha, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20892– 5475 sushmita.purkayastha@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training E:\FR\FM\06JYN1.SGM 06JYN1

Agencies

[Federal Register Volume 86, Number 126 (Tuesday, July 6, 2021)]
[Notices]
[Pages 35520-35521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14314]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Administration for Community Living


Reallotment of FY 2021 Funds: Puerto Rico

AGENCY: Administration on Disabilities (AoD), Administration for 
Community Living (ACL), U.S. Department of Health and Human Services 
(HHS).

ACTION: Notice of reallotment of FY 2021 funds.

-----------------------------------------------------------------------

SUMMARY: The Administration on Disabilities (AoD) intends to reallot 
funds under the authority of the Development Disabilities Assistance 
and Bill of Rights Act of 2000 which states: ``If the Secretary 
determines that an amount of an allotment to a State for a period (of a 
fiscal year or longer) will not be required by the State during the 
period for the purpose for which the allotment was made, the Secretary 
may reallot the amount.''

DATES: Funds will be realloted after August 13, 2021 and before 
September 30, 2021.

FOR FURTHER INFORMATION CONTACT: Allison Cruz, Office of Intellectual 
and Developmental Disabilities, Administration on Disabilities, 
Administration for Community Living, 330 C St. SW, Washington, DC 
20201. Telephone (202) 795-7408. Email [email protected]. Please 
note the telephone number is not toll free. This document will be made 
available in alternative formats upon request.

[[Page 35521]]

Written correspondence can be sent to Administration for Community 
Living, U.S. Department of Health and Human Services, 330 C St. SW, 
Washington, DC 20201.

SUPPLEMENTARY INFORMATION: AoD will be reallotting FY 2021 funds 
awarded to the State Council on Developmental Disabilities (SCDD) 
located within the Commonwealth of Puerto Rico. This determination is 
based on the limited reported expenditures and requests for 
reimbursement over the last several years from the SCDD in the 
Commonwealth of Puerto Rico.
    The Puerto Rico SCDD will have up to $1.8 million rescinded and 
proportionately redistributed to the remaining SCDDs. SCDDs that 
receive FY 2021 realloted funds will have through the end of FY 2022 to 
obligate the funds and until the end of FY 2023 to liquidate the funds. 
Realloted funds for the SCDDs must be used according to the terms as 
outlined in the FY 2021 Notice of Award for each program.

Jennifer G. Johnson,
Deputy Commissioner, Administration on Disabilities.
[FR Doc. 2021-14314 Filed 7-2-21; 8:45 am]
BILLING CODE 4154-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.